Permanent Pediatric Research Laws Would Spur In-House Units – J&J Exec
Executive Summary
Enacting a permanent authorization for federal pediatric research programs would encourage pharmaceutical companies to create dedicated pediatric research programs within their operations, a Johnson & Johnson executive suggested to the Senate Health, Labor and Pensions Committee March 27
You may also be interested in...
PDUFA Draft Bill Adds $70 Mil. For Rx Safety To User Fee Totals; Mark-Up Looms
A draft of the bill to reauthorize FDA's user fee program would add $70 million to the total fee negotiated by the agency and industry in order to pay for additional Rx safety oversight
PDUFA Draft Bill Adds $70 Mil. For Rx Safety To User Fee Totals; Mark-Up Looms
A draft of the bill to reauthorize FDA's user fee program would add $70 million to the total fee negotiated by the agency and industry in order to pay for additional Rx safety oversight
Pediatric Studies Become Costlier; Congress May Make Them Less Profitable
Drug companies are spending eight times more money to carry out a pediatric study than they were six years ago, Tufts University researchers found in a recent industry survey
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: